Controlled release and antiviral activity of acyclovir-loaded PLA/PEG nanofibers produced by solution blow spinning
Source abstract
Abstract
Herpetic dermatitis and oral recurrent herpes (ORH) are among the most common human infections. Antiviral drugs such as acyclovir (ACV) are used in the standard treatment for ORH. Despite its therapeutic efficacy, ACV is continuously and repetitively administered in high doses. In this sense, the development of controlled release drug delivery systems such as core-shell fibers have a great potential in the treatment of ORH. In this work, poly(lactic acid)/poly(ethylene glycol) (PLA/PEG) fibers were produced by solution blow spinning (SBS) for the controlled release of ACV encapsulated in the core. PLA/PEG nanofibers containing four different blend ratios (100:0, 90:10, 80:20 and 70:30 wt%) without or with 10 wt% ACV were characterized by scanning electron microscopy (SEM), thermogravimetry (TG) and differential scanning calorimetry (DSC). The ACV release profile for 21 days was accessed by UV-Vis spectroscopy. Static water contact angles of the spun fiber mats were measured by the sessile drop method to evaluate fiber wettability upon contact with skin for transdermal release. Cytotoxicity and antiviral efficacy against Herpes simplex viruses (HSV-1) were evaluated using Vero cells. ACV addition did not impact on morphology, but slightly improved thermal stability of the fibers. Addition of hydrophilic PEG in PLA/PEG blends, however, increased drug release as confirmed by contact angle measurements and release profile. The in vitro tests showed the effectiveness of the drug delivery systems developed in reducing HSV-1 viral titer, which is related to the judicious combination of polymers used in the fibrous mats, in addition to not being cytotoxic to Vero cells. These results show the great potential of PLA/PEG solution blow-spun fibers in the controlled release of ACV to develop practical devices for the treatment of cold sores, while favoring the aesthetic appearance by covering them with a soft tissue patch (fibrous mats).
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nerve injury and regeneration · Herpesvirus Infections and Treatments · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Worldwide circulation of HSV-2 × HSV-1 recombinant strains
2. Persistence in the population: epidemiology, transmission
3. Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial
4. Persistence in the population: epidemiology, transmission
5. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections10.1093/jac/12.suppl_B.89 ↗
6. Herpes labialis treatment with acyclovir 5 % modified aqueous cream: a double-blind, randomized trial10.1016/0030-4220(89)90007-8 ↗
7. Spruance · 1982 · 146 · 85
8. Oral acyclovir and herpes labialis: a randomized, double-blind, placebo-controlled study10.14219/jada.archive.1987.0211 ↗
9. Herpes simplex virus encephalitis: clinical manifestations, diagnosis and outcome in 106 adult patients
10. Biomaterials multifunctional polymersomes for cytosolic delivery of gemcitabine and doxorubicin to cancer cells
11. Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery
12. Advanced materials and processing for drug delivery: the past and the future10.1016/j.addr.2012.10.003 ↗
13. Nanofibers as novel drug carrier – an overview
14. Solution blow spinning: a new method to produce micro- and nanofibers from polymer solutions10.1002/app.30275 ↗
15. Magaz · 2018
16. Batista · 2017 · 44802 · 1
17. PVDF/Ni fibers synthesis by solution blow spinning technique
18. M.M.O. Simbara · 2018 · 1
19. The support of bone marrow stromal cell differentiation by airbrushed nanofiber scaffolds10.1016/j.biomaterials.2012.12.020 ↗
20. A review of the fundamental principles and applications of solution blow spinning10.1021/acsami.6b12994 ↗
21. Release of the diclofenac sodium by nanofibers of poly(3-hydroxybutyrate- co -3-hydroxyvalerate) obtained from electrospinning and solution blow spinning10.1155/2014/129035 ↗
22. Effectiveness of core-shell nanofibers incorporating amphotericin b by solution blow spinning against Leishmania and Candida species10.3389/fbioe.2020.571821 ↗
23. Development of poly(lactic acid) nanostructured membranes for the controlled delivery of progesterone to livestock animals10.1016/j.msec.2012.10.032 ↗
24. Controlled release of linalool using nanofibrous membranes of poly(lactic acid) obtained by electrospinning and solution blow spinning: a comparative study10.1166/jnn.2015.9692 ↗
25. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering10.1016/j.biomaterials.2006.01.039 ↗
26. Adhesion of mammalian cells to polymer surfaces: from physical chemistry of surfaces to selective adhesion on defined patterns10.1016/S0142-9612(98)00055-6 ↗
27. Diou · 2015
28. Predicting drug loading in PLA-PEG nanoparticles10.1016/j.ijpharm.2017.04.043 ↗
29. Preparation, characterization, and properties of polylactide (PLA)-poly(ethylene glycol) (PEG) copolymers: a potential drug carrier10.1002/app.1990.070390101 ↗
30. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver in fl ammation in streptozotocin-induced diabetic rats10.1016/j.colsurfb.2019.02.024 ↗
31. Antimicrobial activity of PLA/PEG nanofibers containing terpinen-4-ol against aggregatibacter actinomycetemcomitans10.1002/app.45782 ↗
32. In vitro antimicrobial activity of solution blow spun poly(lactic acid)/polyvinylpyrrolidone nanofibers loaded with copaiba (Copaifera sp.) oil10.1016/j.msec.2014.12.021 ↗
33. Oliveira · 2018
34. Design and optimization of floating drug delivery system of acyclovir10.4103/0250-474X.78527 ↗
35. In vitro effect of cinnamomum zeylanicum blume essential oil on Candida spp. involved in oral infections
36. A simple method of estimating fifty per cent endpoints10.1093/oxfordjournals.aje.a118408 ↗
37. Nano and submicrometric fibers of poly(D, L-Lactide) obtained by solution blow spinning: process and solution variables
38. Garlotta · 2002 · 9
39. Lj · 2004 · 364 · 355
40. Thermal stability and decomposition kinetic studies of acyclovir and zidovudine drug compounds10.1208/s12249-012-9916-y ↗
41. Mechanical and thermal properties of PLA composites with cellulose nanofibers and standard size fibers10.1016/j.compositesa.2011.07.003 ↗
42. Preparation of PLLA/PEG nanofibers by electrospinning and potential applications10.1177/0883911506073570 ↗
43. Development of semisolid self-microemulsifying drug delivery systems (SMEDDSs) filled in hard capsules for oral delivery of aciclovir10.1016/j.ijpharm.2017.06.028 ↗
44. Biodegradable polymer blends of poly (lactic acid) and poly (ethylene glycol)10.1002/(SICI)1097-4628(19971121)66:8<1495::AID-APP10>3.0.CO;2-3 ↗
45. Utilizing hydrophobic/hydrophilic interactions in biomaterials: old dog, new tricks!
46. Zhu · 2015 · 5063
47. Wu · 2018
48. Conti · 1997 · 5 · 287
49. Jalon · 2001 · 75 · 191
50. Effect of acyclovir solid lipid nanoparticles for the treatment of herpes simplex virus (HSV) infection in an animal model of HSV-1 infection
51. Current applications of biopolymer-based nanofibers as drug delivery systems and scaffolds
52. Polymeric electrospun fibrous dressings for topical co-delivery of acyclovir and Omega-3 fatty acids10.3389/fbioe.2019.00390 ↗
53. Structure − activity relationships of GAG mimetic-functionalized mesoporous silica nanoparticles and evaluation of acyclovir-loaded antiviral nanoparticles with dual mechanisms of action
54. Enhanced antiviral activity of acyclovir loaded into β -cyclodextrin-poly (4-acryloylmorpholine) conjugate nanoparticles10.1016/j.jconrel.2009.04.004 ↗
55. Increased efficacy of acyclovir-loaded microparticles against herpes simplex virus type 1 in cell culture10.1016/S0939-6411(03)00068-7 ↗